AUMED representatives participated in the XL. Congress of Slovak and Czech allergists and clinical immunologists, which took place from October 22 to 25, 2025 in Horní Smokovec. As in 2023, AUMED had its own promotional stand at the congress, focused mainly on the immunological preparation TFI based on transfer factor, which was a huge success. In the form of posters, leaflets and personal interviews, we shared with the professional public our successes in the development of the preparation and ongoing clinical trials.
We believe that AUMED, a.s. will successfully complete clinical trials and register the preparation TFI in several European markets. We hope that in two years we will be able to inform medical professionals about the availability of the preparation on the market.
The Beginnings and Establishment of the State Health Institute (SZÚ) AUMED, a.s. is the proud successor to an almost century-long…
AUMED representatives participated in the XL. Congress of Slovak and Czech allergists and clinical immunologists, which took place from October…
AUMED has received support for the project titled “Development of an Immunization Product for Protection Against the Causative Agent of…
Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.
Ministry of Industry and Trade
Program TRIO
European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness
Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s
